Rayk Behrendt Selected Research

Proteins (Proteins, Gene)

1/2018	Targeting STING with covalent small-molecule inhibitors.
1/2017	Constitutive Kit activity triggers B-cell acute lymphoblastic leukemia-like disease in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rayk Behrendt Research Topics

Disease

6	Bites and Stings (Sting) 01/2023 - 01/2018
4	Autoimmune Diseases (Autoimmune Disease) 03/2024 - 08/2013
4	Neoplasms (Cancer) 02/2023 - 01/2018
4	Inflammation (Inflammations) 01/2023 - 01/2016
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 02/2023 - 08/2013
3	Infections 01/2022 - 01/2013
2	Vasculitis (Vasculitides) 12/2022 - 10/2022
2	Asthma (Bronchial Asthma) 11/2021 - 09/2014
1	Lung Neoplasms (Lung Cancer) 10/2023
1	Systemic Scleroderma (Systemic Sclerosis) 02/2023
1	Melanoma (Melanoma, Malignant) 01/2023
1	Genomic Instability 01/2023
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 10/2022
1	Hemorrhage 10/2022
1	Viremia 01/2022
1	Eczema 11/2021
1	Dermatitis 11/2021
1	Hypothermia 01/2020
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2019
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2018
1	Mastocytosis 01/2017
1	Hypersensitivity (Allergy) 09/2014
1	Virus Diseases (Viral Diseases) 01/2013

Drug/Important Bio-Agent (IBA)

6	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 01/2018
5	Nucleic AcidsIBA 03/2024 - 04/2021
4	Interferon Type IIBA 01/2023 - 08/2013
4	CytokinesIBA 04/2021 - 01/2013
3	Antiviral Agents (Antivirals)IBA 04/2021 - 01/2013
2	Ribonucleases (Ribonuclease)IBA 02/2023 - 10/2018
2	EnzymesIBA 01/2023 - 01/2016
2	RibonucleotidesIBA 01/2023 - 10/2018
2	InterferonsIBA 01/2023 - 01/2018
2	Immunoglobulin E (IgE)IBA 11/2021 - 09/2014
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2017
2	exodeoxyribonuclease IIBA 01/2016 - 06/2014
2	Interleukin-10 (Interleukin 10)IBA 01/2016 - 01/2013
1	Lamin Type A (Lamin A)IBA 10/2023
1	LigandsIBA 01/2023
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 01/2023
1	A-Form DNA (A-DNA)IBA 01/2023
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 10/2022
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 10/2022
1	AllergensIBA 11/2021
1	Peptides (Polypeptides)IBA 04/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020
1	LipopolysaccharidesIBA 01/2020
1	Neuropilin-2IBA 01/2019
1	Indicators and Reagents (Reagents)IBA 01/2019
1	Cysteine (L-Cysteine)FDA Link 01/2018
1	Pattern Recognition ReceptorsIBA 01/2018
1	Messenger RNA (mRNA)IBA 01/2013

Therapy/Procedure

3	Therapeutics 10/2022 - 01/2018
1	Immunotherapy 01/2023
1	Radiotherapy 01/2023